The Valley Desk

NCT01451827 · Interventional trial

8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Overall registry status Completed

Phase 2

Conditions Autosomal Dominant Polycystic Kidney Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov